Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2023-09-05 00:00:00 ET · period of report 2023-08-31 · accession 0000874015-23-000190 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-05 | 2023-08-31 | IONS | Monia Brett P | CEO Level 15, Dir | J - Other | $30.56 | +157 | 121.9K | +0.1% | +$4,798 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-31 | J | A | 157 | $30.56 | 121,881 | D | — | — |